Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomas

[1]  G. Nemerow,et al.  Integrin αvβ1 Is an Adenovirus Coreceptor , 2001, Journal of Virology.

[2]  R. Kreienberg,et al.  Adenoviral Transduction Efficiency of Ovarian Cancer Cells Can Be Limited by Loss of Integrin β3 Subunit Expression and Increased by Reconstitution of Integrin αvβ3 , 2001 .

[3]  J. Dye,et al.  Phenotype of the endothelium in the human term placenta. , 2001, Placenta.

[4]  R. Kreienberg,et al.  Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphavbeta3. , 2001, Human gene therapy.

[5]  M. Widschwendter,et al.  New insights into p53 regulation and gene therapy for cancer. , 2000, Biochemical pharmacology.

[6]  B. Hann,et al.  Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015) , 2000, Nature Medicine.

[7]  L. Johnson,et al.  An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy , 2000, Nature Medicine.

[8]  J. Bergelson,et al.  The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy. , 2000, Cancer research.

[9]  H. Abe,et al.  Dependence of efficient adenoviral gene delivery in malignant glioma cells on the expression levels of the Coxsackievirus and adenovirus receptor. , 2000, Journal of neurosurgery.

[10]  A. Tamanini,et al.  Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. , 2000, Virology.

[11]  B. Neustadt,et al.  Targeting Integrins αvβ3 and αvβ5 for Bloking Tumor-Induced Angiogenesis , 2000 .

[12]  N. Hackett,et al.  Free cholesterol enhances adenoviral vector gene transfer and expression in CAR-deficient cells. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[13]  B. Neustadt,et al.  Targeting integrins alpha v beta 3 and alpha v beta 5 for blocking tumor-induced angiogenesis. , 2000, Advances in experimental medicine and biology.

[14]  S. Kim,et al.  Regulation of integrin alpha vbeta 3-mediated endothelial cell migration and angiogenesis by integrin alpha5beta1 and protein kinase A. , 2000, The Journal of biological chemistry.

[15]  D. Curiel,et al.  Detection of Coxsackie–Adenovirus Receptor (CAR) Immunoreactivity in Ovarian Tumors of Epithelial Derivation , 1999 .

[16]  R. Walker,et al.  Integrins: a role as cell signalling molecules. , 1999, Molecular pathology : MP.

[17]  Jhingook Kim,et al.  Intraperitoneal gene therapy with adenoviral-mediated p53 tumor suppressor gene for ovarian cancer model in nude mouse , 1999, Cancer Gene Therapy.

[18]  R. Crystal,et al.  CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts. , 1999, The Journal of clinical investigation.

[19]  A. Sagalowsky,et al.  Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. , 1999, Cancer research.

[20]  R. Kreienberg,et al.  p53 mutations and expression in ovarian cancers: correlation with overall survival. , 1999, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[21]  C. Miller,et al.  Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer. , 1998, Cancer Research.

[22]  C. Miller,et al.  An Adenovirus Vector with Genetically Modified Fibers Demonstrates Expanded Tropism via Utilization of a Coxsackievirus and Adenovirus Receptor-Independent Cell Entry Mechanism , 1998, Journal of Virology.

[23]  R. Dummer,et al.  The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures. , 1998, Human gene therapy.

[24]  G. Rodan,et al.  The αvβ3 Integrin Regulates α5β1-mediated Cell Migration toward Fibronectin* , 1997, The Journal of Biological Chemistry.

[25]  L. Duan,et al.  Optimizing Suicide Gene Therapy for Head and Neck Cancer , 1997, The Laryngoscope.

[26]  D. Curiel,et al.  Adenovirus type 5 fiber knob binds to MHC class I α2 domain at the surface of human epithelial and B lymphoblastoid cells , 1997, The EMBO journal.

[27]  J. Rader,et al.  Expression of αvβ3 integrin is less frequent in ovarian epithelial tumors of low malignant potential in contrast to ovarian carcinomas , 1997 .

[28]  E. Maxwell,et al.  Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts. , 1997, Cancer gene therapy.

[29]  J. Bergelson,et al.  Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5 , 1997, Science.

[30]  J. Rader,et al.  Expression of alpha(v)beta3 integrin is less frequent in ovarian epithelial tumors of low malignant potential in contrast to ovarian carcinomas. , 1997, Human pathology.

[31]  D. Alberts,et al.  Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. , 1996, The New England journal of medicine.

[32]  A. Fattaey,et al.  An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells , 1996, Science.

[33]  Y. Denoux,et al.  Expression and localization of alpha v integrins and their ligand vitronectin in normal ovarian epithelium and in ovarian carcinoma. , 1996, Gynecologic oncology.

[34]  A. Monnier,et al.  Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  Jeffrey W. Smith,et al.  A Biochemical Characterization of the Binding of Osteopontin to Integrins αvβ1 and αvβ5(*) , 1995, The Journal of Biological Chemistry.

[36]  A. Passaniti,et al.  Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of prostatic tumor cells. , 1995, Cancer research.

[37]  M. Rollence,et al.  Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain , 1995, Journal of virology.

[38]  J. Roth,et al.  In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. , 1995, Cancer research.

[39]  E. Oldfield,et al.  Heterogeneity of subcellular localization of p53 protein in human glioblastomas. , 1994, Cancer research.

[40]  G. Nemerow,et al.  Integrins α v β 3 and α v β 5 promote adenovirus internalization but not virus attachment , 1993, Cell.

[41]  W. Schleif,et al.  A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses , 1988, Journal of virology.